Stereotaxis Inc (STXS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Release Date: May 12, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Stereotaxis Inc (STXS) reported a solid 9% year-over-year revenue growth for Q1 2025.
The company is seeing commercial progress with its differentiated EP catheters, including the recently approved Magic catheter in Europe.
Recurring revenue growth is driven by the Mapi family of diagnostic EP catheters, with sales in the US growing 30% sequentially.
Stereotaxis Inc (STXS) received European approval for the Magic ablation catheter, with initial sales expected to ramp up significantly.
The company is preparing for the first commercial installation of Genesis X, which is expected to drive robotic system growth.
Structural challenges of the old product ecosystem remain a significant headwind for Stereotaxis Inc (STXS).
The process of getting catheters adopted is gradual, requiring administrative efforts and clinical support.
Recurring revenue gross margins are impacted by acquisition-related accounting, temporarily reducing disposable margins.
Operating loss and net loss increased compared to the previous year, with operating expenses rising due to acquisition-related costs.
Uncertainty in the Chinese market and macroeconomic conditions could impact potential revenue from Genesis systems.
Warning! GuruFocus has detected 8 Warning Signs with STXS.
Q: Can you provide more details on the backlog for Genesis and Genesis X systems in the US and Europe, and how the capital equipment environment is affecting these? A: David Fischer, CEO: The capital environment varies by region. In the US, the ecosystem is less advanced due to pending approvals for Genesis X and related catheters. Interest exists, but actionable steps await regulatory clearance. In Europe, there's a robust pipeline for both Genesis and Genesis X, with some hospitals already planning for Genesis. In China, despite macroeconomic uncertainties, there's potential upside with recent regulatory approval.
Q: How is the Magic RF ablation catheter performing in Europe, and what is the expected scaling over the next quarters? A: David Fischer, CEO: The reception has been positive, with usage across a variety of procedures. The catheter is predominantly used in complex cases like VTs and PVCs. We expect Magic to reach a $1 million quarterly run rate in Europe by year-end, with full market conversion anticipated over two years.
Q: What are the ordering patterns for the 20% of European customers using Magic, and how is the adoption process? A: David Fischer, CEO: Initial orders typically consist of 5-10 catheters, with hospitals testing them before full adoption. Feedback has been positive, and repeat orders are starting. The adoption process involves hospital reviews and national approvals, which is progressing well.
Q: What is the status of the Magic catheter's FDA approval in the US, and what remains in the submission process? A: David Fischer, CEO: The FDA review is ongoing, with detailed questions being addressed. Most supplementary tests are complete, and clinical data from European studies are being shared with the FDA. An on-site audit may be required, but the timeline for approval remains realistic for the second half of the year.
Q: How do you envision the case mix for robotic magnetic navigation cardiac ablation procedures evolving with the expanded catheter portfolio? A: David Fischer, CEO: The focus remains on complex cases like VTs, PVCs, and congenital patients, where robotic navigation offers the most value. While there's potential to expand into atrial ablations, the current strategy is to capitalize on the significant growth opportunity within complex ablations.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
28 minutes ago
- Wall Street Journal
China's Downward Price Pressures Deepened in May
China's downward price pressures deepened in May, with factory-gate prices falling at the fastest pace in more than a year amid looming trade uncertainties. China's producer-price index dropped 3.3% from a year earlier, widening from April's 2.7% decline and keeping the gauge in negative territory for more than two years, data released by the National Bureau of Statistics showed Monday.
Yahoo
an hour ago
- Yahoo
US, China seek to extend trade truce with London talks
After a round of talks in Geneva last month, the United States and China will sit down at the negotiating table in London on Monday to attempt to preserve a fragile truce on trade, despite simmering tensions. US Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and Trade Representative Jamieson Greer will lead the US delegation, President Donald Trump announced Friday. Chinese Vice Premier He Lifeng -- who led Beijing's negotiating team in Geneva -- will also lead the team in London, the foreign ministry announced at the weekend. "The meeting should go very well," Trump said in a post on his Truth Social platform. His press secretary, Karoline Leavitt, told Fox News on Sunday: "We want China and the United States to continue moving forward with the agreement that was struck in Geneva." While the government of UK Prime Minister Keir Starmer reiterated that it was not involved in the content of the discussions in any way, a spokesperson said: "We are a nation that champions free trade." UK authorities "have always been clear that a trade war is in nobody's interests, so we welcome these talks," the spokesperson added. - 'Correcting the course' - The talks in London come just a few days after Trump and Chinese President Xi Jinping finally held their first publicly announced telephone talks since the Republican returned to the White House. Trump said that call, which took place on Thursday, had reached a "very positive conclusion." Xi was quoted by state-run news agency Xinhua as saying that "correcting the course of the big ship of Sino-US relations requires us to steer well and set the direction." The call came after tensions between the world's two biggest economies had soared, with Trump accusing Beijing of violating a tariff de-escalation deal reached in Geneva in mid-May. "We need China to comply with their side of the deal. And so that's what the trade team will be discussing tomorrow," Leavitt said Sunday. In April, Trump introduced sweeping worldwide tariffs that targeted China most heavily. At one point the United States hit China with additional levies of 145 percent on its goods as both sides engaged in tit-for-tat escalation. China's countermeasures on US goods reached 125 percent. Then in Switzerland, after two days of talks, the two sides agreed to slash their staggeringly high tariffs for 90 days. But differences have persisted, including over China's restrictions on the export of rare earth minerals used in tech products. - 'Green channel' - Throughout its talks with Washington, China also has launched discussions with other trading partners -- including Japan and South Korea -- in a bid to build a united front to counter Trump's tariffs. On Thursday, Beijing turned to Canada, with the two sides agreeing to regularize their channels of communication after a period of strained ties. Canadian Prime Minister Mark Carney and Chinese Premier Li Qiang also discussed trade and the fentanyl crisis, Ottawa said. Beijing proposed establishing a "green channel" to ease the export of rare earths to the European Union, and fast-tracking approval of some export licenses. That proposal from the commerce ministry in Beijing came after talks on Tuesday between China's Commerce Minister Wang Wentao and EU Trade Commissioner Maros Sefcovic. China is expected to host a summit with the EU in July, marking 50 years since Beijing and Brussels established diplomatic ties. bur-els/sst/aha
Yahoo
an hour ago
- Yahoo
Barcelona star set for €12 million exit
An altogether noteworthy update on the incoming departure of Barcelona starlet Ansu Fati has this weekend surfaced online. This comes amid claims that, contrary to previous speculation, the 22-year-old's summer exit will come with the certainty of bringing a permanent close to his Blaugrana stint. Advertisement Ansu's name has of course proven a prominent one in the headlines across Europe for several weeks now. This comes after AS Monaco opened talks with their Barcelona counterparts, over bringing the winger to Ligue 1 for next season. After Ansu struggled for game-time under the watch of new boss Hansi Flick in Catalunya's capital this past season, Deco and co. quickly opened to the prospect of a sale. Initially, the understanding was that as much would come by way of a loan, featuring an option to buy. As alluded to above, though, if the latest word stemming from the media on Saturday is anything to go by, Monaco's clause at the end of the 2025/26 campaign will in fact come in the form of a permanent one. Advertisement As per a report from Diario AS: 'In principle, Ansu's departure will be via loan with a mandatory purchase option of 12 million euros. There are still some minor details to be resolved because Barcelona want to include a percentage of a future sale or a possible buy-back option.' Conor Laird – GSFN
